Literature DB >> 29382959

The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder.

Melissa DeFilippis1.   

Abstract

Complementary alternative medicine (CAM) is used to a greater degree in children and adolescents with autism spectrum disorder (ASD), when compared to children and adolescents without this diagnosis. There is limited evidence supporting the use of many of these treatments in ASD, despite their popularity. Current FDA approved medications for ASD target associated behavioral symptoms of the diagnosis, not the core symptoms of social communication deficits and restricted/repetitive behaviors. These medications are also associated with concerning adverse effects. Evidence-based therapies for core symptoms, such as applied behavior analysis (ABA), are sometimes difficult for families to access for various reasons. Families are sometimes hesitant to discuss their interest in CAM with physicians. Physicians report knowledge gaps about CAM and their use in ASD and concerns about potential conflict with parents regarding differing beliefs of CAM's role in the management of ASD. It is important for physicians to know the current evidence which examines the use of CAM treatments in children and adolescents with autism so that they may have conversations with families which are informed and evidence-based.

Entities:  

Keywords:  alternative; autism; complementary; symptoms; treatment

Mesh:

Year:  2018        PMID: 29382959      PMCID: PMC5765434     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  90 in total

1.  A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.

Authors:  W M Bolman; J A Richmond
Journal:  J Autism Dev Disord       Date:  1999-06

2.  Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial.

Authors:  Sujeeva A Munasinghe; Carolyn Oliff; Judith Finn; John A Wray
Journal:  J Autism Dev Disord       Date:  2010-09

3.  Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder.

Authors:  James B Adams; Charles Holloway
Journal:  J Altern Complement Med       Date:  2004-12       Impact factor: 2.579

4.  Using the preschool language scale, fourth edition to characterize language in preschoolers with autism spectrum disorders.

Authors:  Joanne Volden; Isabel M Smith; Peter Szatmari; Susan Bryson; Eric Fombonne; Pat Mirenda; Wendy Roberts; Tracy Vaillancourt; Charlotte Waddell; Lonnie Zwaigenbaum; Stelios Georgiades; Eric Duku; Ann Thompson
Journal:  Am J Speech Lang Pathol       Date:  2011-04-08       Impact factor: 2.408

Review 5.  Combined vitamin B6-magnesium treatment in autism spectrum disorder.

Authors:  C Nye; A Brice
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.

Authors:  Juthamas Wirojanan; Sebastien Jacquemont; Rafael Diaz; Susan Bacalman; Thomas F Anders; Randi J Hagerman; Beth L Goodlin-Jones
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

7.  Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD).

Authors:  Martha Spilioti; Athanasios E Evangeliou; Despoina Tramma; Zoe Theodoridou; Spyridon Metaxas; Eleni Michailidi; Eleni Bonti; Helen Frysira; A Haidopoulou; Despoina Asprangathou; Aggelos J Tsalkidis; Panagiotis Kardaras; Ron A Wevers; Cornelis Jakobs; K Michael Gibson
Journal:  Front Hum Neurosci       Date:  2013-12-24       Impact factor: 3.169

8.  Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Authors:  Daniel A Rossignol; Lanier W Rossignol; Scott Smith; Cindy Schneider; Sally Logerquist; Anju Usman; Jim Neubrander; Eric M Madren; Gregg Hintz; Barry Grushkin; Elizabeth A Mumper
Journal:  BMC Pediatr       Date:  2009-03-13       Impact factor: 2.125

9.  Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results.

Authors:  James B Adams; Matthew Baral; Elizabeth Geis; Jessica Mitchell; Julie Ingram; Andrea Hensley; Irene Zappia; Sanford Newmark; Eva Gehn; Robert A Rubin; Ken Mitchell; Jeff Bradstreet; Jane El-Dahr
Journal:  BMC Clin Pharmacol       Date:  2009-10-23

10.  Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study.

Authors:  R E Frye; R DeLatorre; H B Taylor; J Slattery; S Melnyk; N Chowdhury; S J James
Journal:  Transl Psychiatry       Date:  2013-03-05       Impact factor: 6.222

View more
  8 in total

1.  Parents' experiences of information-seeking and decision-making regarding complementary medicine for children with autism spectrum disorder: a qualitative study.

Authors:  Caroline A Smith; Chloe Parton; Marlee King; Gisselle Gallego
Journal:  BMC Complement Med Ther       Date:  2020-01-13

2.  Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic review.

Authors:  Gian Loreto D'Alò; Franco De Crescenzo; Laura Amato; Fabio Cruciani; Marina Davoli; Francesca Fulceri; Silvia Minozzi; Zuzana Mitrova; Gian Paolo Morgano; Franco Nardocci; Rosella Saulle; Holger Jens Schünemann; Maria Luisa Scattoni
Journal:  BMC Psychiatry       Date:  2020-11-25       Impact factor: 3.630

3.  Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial.

Authors:  Maria Jose de la Torre-Aguilar; Antonio Gomez-Fernandez; Katherine Flores-Rojas; Pilar Martin-Borreguero; María Dolores Mesa; Juan Luis Perez-Navero; Mónica Olivares; Angel Gil; Mercedes Gil-Campos
Journal:  Front Nutr       Date:  2022-03-29

Review 4.  Medicine Insufficient Evidence for the Efficacy of Massage as Intervention for Autism Spectrum Disorder: A Systematic Review.

Authors:  Hui Ruan; Wichai Eungpinichpong; Hua Wu; Minggui Shen; Aijiao Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-24       Impact factor: 2.650

5.  Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: results from a multi-center survey.

Authors:  Juliana Höfer; Falk Hoffmann; Inge Kamp-Becker; Charlotte Küpper; Luise Poustka; Stefan Roepke; Veit Roessner; Sanna Stroth; Nicole Wolff; Christian J Bachmann
Journal:  BMC Psychiatry       Date:  2019-02-01       Impact factor: 3.630

6.  Equity, acceptability and feasibility of using polyunsaturated fatty acids in children and adolescents with autism spectrum disorder: a rapid systematic review.

Authors:  Gian Loreto D'Alò; Franco De Crescenzo; Silvia Minozzi; Gian Paolo Morgano; Zuzana Mitrova; Maria Luisa Scattoni; Laura Amato; Marina Davoli; Holger J Schünemann
Journal:  Health Qual Life Outcomes       Date:  2020-04-16       Impact factor: 3.186

7.  Safety and efficacy of complementary and alternative medicine in the treatment of autism spectrum disorder: A protocol for systematic review and meta-analysis.

Authors:  Biqin Shuai; Hongjiao Jin; Yong Lin; Renrong Duan; Ning Zhao; Zhu Li; Jiao Mao; Yan Luo; Mengyu Shi
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

8.  Alterations in Gut Vitamin and Amino Acid Metabolism are Associated with Symptoms and Neurodevelopment in Children with Autism Spectrum Disorder.

Authors:  Jiang Zhu; Xueying Hua; Ting Yang; Min Guo; Qiu Li; Lu Xiao; Ling Li; Jie Chen; Tingyu Li
Journal:  J Autism Dev Disord       Date:  2021-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.